

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 7.09432482 |
| 2 | cullin deneddylation (GO:0010388) | 4.87982659 |
| 3 | indole-containing compound catabolic process (GO:0042436) | 4.44574610 |
| 4 | indolalkylamine catabolic process (GO:0046218) | 4.44574610 |
| 5 | tryptophan catabolic process (GO:0006569) | 4.44574610 |
| 6 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.42387658 |
| 7 | protein deneddylation (GO:0000338) | 4.40527456 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 4.22054238 |
| 9 | maturation of SSU-rRNA (GO:0030490) | 4.16989610 |
| 10 | L-phenylalanine catabolic process (GO:0006559) | 3.96766142 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.96766142 |
| 12 | tryptophan metabolic process (GO:0006568) | 3.96108827 |
| 13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.90092711 |
| 14 | negative T cell selection (GO:0043383) | 3.85472626 |
| 15 | amine catabolic process (GO:0009310) | 3.81807964 |
| 16 | cellular biogenic amine catabolic process (GO:0042402) | 3.81807964 |
| 17 | NAD biosynthetic process (GO:0009435) | 3.75895942 |
| 18 | L-phenylalanine metabolic process (GO:0006558) | 3.69737626 |
| 19 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.69737626 |
| 20 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.69432362 |
| 21 | negative thymic T cell selection (GO:0045060) | 3.61381797 |
| 22 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.58389108 |
| 23 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.47928556 |
| 24 | presynaptic membrane organization (GO:0097090) | 3.47464287 |
| 25 | T cell migration (GO:0072678) | 3.44157639 |
| 26 | presynaptic membrane assembly (GO:0097105) | 3.40931497 |
| 27 | cellular response to interleukin-15 (GO:0071350) | 3.34693495 |
| 28 | negative regulation of cell killing (GO:0031342) | 3.28540546 |
| 29 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.28540546 |
| 30 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.27979487 |
| 31 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.27924790 |
| 32 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.27515487 |
| 33 | urea metabolic process (GO:0019627) | 3.26012197 |
| 34 | urea cycle (GO:0000050) | 3.26012197 |
| 35 | cellular response to exogenous dsRNA (GO:0071360) | 3.25209889 |
| 36 | regulation of regulatory T cell differentiation (GO:0045589) | 3.24351166 |
| 37 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.22475555 |
| 38 | surfactant homeostasis (GO:0043129) | 3.19645588 |
| 39 | bile acid biosynthetic process (GO:0006699) | 3.18962101 |
| 40 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.16812934 |
| 41 | B cell receptor signaling pathway (GO:0050853) | 3.16362141 |
| 42 | kynurenine metabolic process (GO:0070189) | 3.15160857 |
| 43 | positive T cell selection (GO:0043368) | 3.14328521 |
| 44 | regulation of chronic inflammatory response (GO:0002676) | 3.12431087 |
| 45 | nitrogen cycle metabolic process (GO:0071941) | 3.11470332 |
| 46 | viral transcription (GO:0019083) | 3.07303898 |
| 47 | tolerance induction (GO:0002507) | 3.07018564 |
| 48 | indolalkylamine metabolic process (GO:0006586) | 3.04688062 |
| 49 | regulation of activation of Janus kinase activity (GO:0010533) | 3.03437071 |
| 50 | immunoglobulin mediated immune response (GO:0016064) | 3.03093206 |
| 51 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.00754008 |
| 52 | B cell mediated immunity (GO:0019724) | 2.98772077 |
| 53 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.97327040 |
| 54 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.97327040 |
| 55 | translational termination (GO:0006415) | 2.97322810 |
| 56 | response to peptidoglycan (GO:0032494) | 2.97218880 |
| 57 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.96488203 |
| 58 | aromatic amino acid family metabolic process (GO:0009072) | 2.96447521 |
| 59 | mast cell activation (GO:0045576) | 2.94659721 |
| 60 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.94575409 |
| 61 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.94575409 |
| 62 | mature B cell differentiation (GO:0002335) | 2.92269022 |
| 63 | positive regulation of interleukin-17 production (GO:0032740) | 2.91926201 |
| 64 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.90731171 |
| 65 | lymphocyte costimulation (GO:0031294) | 2.88842426 |
| 66 | positive regulation of isotype switching (GO:0045830) | 2.88601440 |
| 67 | neutrophil activation involved in immune response (GO:0002283) | 2.88096029 |
| 68 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.87856428 |
| 69 | T cell costimulation (GO:0031295) | 2.87077846 |
| 70 | positive regulation of DNA recombination (GO:0045911) | 2.86441896 |
| 71 | positive regulation of interleukin-2 production (GO:0032743) | 2.86386443 |
| 72 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.86350942 |
| 73 | cytidine deamination (GO:0009972) | 2.86051714 |
| 74 | cytidine metabolic process (GO:0046087) | 2.86051714 |
| 75 | cytidine catabolic process (GO:0006216) | 2.86051714 |
| 76 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.85569004 |
| 77 | cotranslational protein targeting to membrane (GO:0006613) | 2.85006189 |
| 78 | protein targeting to ER (GO:0045047) | 2.83906787 |
| 79 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.79536531 |
| 80 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.78820808 |
| 81 | aldehyde catabolic process (GO:0046185) | 2.78215470 |
| 82 | response to interleukin-15 (GO:0070672) | 2.77406951 |
| 83 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.77099783 |
| 84 | morphogenesis of an endothelium (GO:0003159) | 2.76734388 |
| 85 | endothelial tube morphogenesis (GO:0061154) | 2.76734388 |
| 86 | negative regulation of B cell proliferation (GO:0030889) | 2.76200149 |
| 87 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.75827076 |
| 88 | T cell selection (GO:0045058) | 2.75671464 |
| 89 | complement activation, alternative pathway (GO:0006957) | 2.75002578 |
| 90 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.74241855 |
| 91 | negative regulation of lipase activity (GO:0060192) | 2.73688930 |
| 92 | positive regulation of B cell mediated immunity (GO:0002714) | 2.73611251 |
| 93 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.73611251 |
| 94 | superoxide anion generation (GO:0042554) | 2.73587701 |
| 95 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.73290978 |
| 96 | high-density lipoprotein particle remodeling (GO:0034375) | 2.72672870 |
| 97 | regulation of cholesterol esterification (GO:0010872) | 2.72357418 |
| 98 | positive regulation of activated T cell proliferation (GO:0042104) | 2.71798249 |
| 99 | positive thymic T cell selection (GO:0045059) | 2.70250600 |
| 100 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.70226854 |
| 101 | translational elongation (GO:0006414) | 2.69598038 |
| 102 | NIK/NF-kappaB signaling (GO:0038061) | 2.68526568 |
| 103 | protein localization to endoplasmic reticulum (GO:0070972) | 2.67729602 |
| 104 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.67594898 |
| 105 | negative regulation of phagocytosis (GO:0050765) | 2.67054488 |
| 106 | phospholipid efflux (GO:0033700) | 2.66920680 |
| 107 | positive regulation of cell killing (GO:0031343) | 2.65452225 |
| 108 | blood coagulation, intrinsic pathway (GO:0007597) | 2.64748385 |
| 109 | multicellular organism reproduction (GO:0032504) | 2.64352582 |
| 110 | regulation of mitochondrial translation (GO:0070129) | 2.63455439 |
| 111 | mature B cell differentiation involved in immune response (GO:0002313) | 2.63005130 |
| 112 | regulation of B cell proliferation (GO:0030888) | 2.62927710 |
| 113 | bile acid metabolic process (GO:0008206) | 2.62547150 |
| 114 | fatty acid elongation (GO:0030497) | 2.62092591 |
| 115 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.61983064 |
| 116 | protein carboxylation (GO:0018214) | 2.61983064 |
| 117 | T cell receptor signaling pathway (GO:0050852) | 2.61579373 |
| 118 | regulation of B cell differentiation (GO:0045577) | 2.60578372 |
| 119 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.59732895 |
| 120 | production of molecular mediator of immune response (GO:0002440) | 2.59602833 |
| 121 | ribosomal large subunit biogenesis (GO:0042273) | 2.59451691 |
| 122 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.58749469 |
| 123 | omega-hydroxylase P450 pathway (GO:0097267) | 2.56449695 |
| 124 | oligosaccharide catabolic process (GO:0009313) | 2.56366265 |
| 125 | B cell proliferation (GO:0042100) | 2.55827940 |
| 126 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.55473389 |
| 127 | natural killer cell activation involved in immune response (GO:0002323) | 2.55220982 |
| 128 | tRNA modification (GO:0006400) | 2.55134290 |
| 129 | cellular glucuronidation (GO:0052695) | 2.54356071 |
| 130 | imidazole-containing compound metabolic process (GO:0052803) | 2.54264489 |
| 131 | regulation of cell killing (GO:0031341) | 2.53318693 |
| 132 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.53313429 |
| 133 | cholesterol efflux (GO:0033344) | 2.53071572 |
| 134 | ribosomal small subunit assembly (GO:0000028) | 2.52909070 |
| 135 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.51882793 |
| 136 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 2.51853944 |
| 137 | negative regulation of mast cell activation (GO:0033004) | 2.51313218 |
| 138 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.51243955 |
| 139 | positive regulation of immunoglobulin production (GO:0002639) | 2.51170311 |
| 140 | positive regulation of interferon-gamma production (GO:0032729) | 2.51149318 |
| 141 | positive regulation of T cell proliferation (GO:0042102) | 2.50851029 |
| 142 | positive regulation of B cell differentiation (GO:0045579) | 2.50828427 |
| 143 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.50532216 |
| 144 | proteasome assembly (GO:0043248) | 2.50182454 |
| 145 | thymic T cell selection (GO:0045061) | 2.50038140 |
| 146 | neutrophil activation (GO:0042119) | 2.49903230 |
| 147 | centriole assembly (GO:0098534) | 2.46309308 |
| 148 | detection of bacterium (GO:0016045) | 2.46060465 |
| 149 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.45915885 |
| 150 | interferon-gamma production (GO:0032609) | 2.45890767 |
| 151 | B cell homeostasis (GO:0001782) | 2.45209655 |
| 152 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.45196725 |
| 153 | positive regulation of humoral immune response (GO:0002922) | 2.44720286 |
| 154 | drug transmembrane transport (GO:0006855) | 2.44448669 |
| 155 | detection of other organism (GO:0098543) | 2.44380482 |
| 156 | positive regulation of T cell apoptotic process (GO:0070234) | 2.44062563 |
| 157 | dendritic cell chemotaxis (GO:0002407) | 2.44047905 |
| 158 | regulation of triglyceride catabolic process (GO:0010896) | 2.43776438 |
| 159 | regulation of protein activation cascade (GO:2000257) | 2.43675146 |
| 160 | response to type I interferon (GO:0034340) | 2.42567883 |
| 161 | regulation of fibrinolysis (GO:0051917) | 2.42448681 |
| 162 | chemical homeostasis within a tissue (GO:0048875) | 2.42196366 |
| 163 | uronic acid metabolic process (GO:0006063) | 2.42040985 |
| 164 | glucuronate metabolic process (GO:0019585) | 2.42040985 |
| 165 | protein activation cascade (GO:0072376) | 2.39204625 |
| 166 | complement activation, classical pathway (GO:0006958) | 2.38856745 |
| 167 | low-density lipoprotein particle remodeling (GO:0034374) | 2.38553378 |
| 168 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.38254009 |
| 169 | germinal center formation (GO:0002467) | 2.37868269 |
| 170 | androgen biosynthetic process (GO:0006702) | 2.36795260 |
| 171 | cysteine metabolic process (GO:0006534) | 2.36053800 |
| 172 | DNA deamination (GO:0045006) | 2.34807653 |
| 173 | response to nitrosative stress (GO:0051409) | 2.34652438 |
| 174 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.34185874 |
| 175 | tyrosine metabolic process (GO:0006570) | 2.34155067 |
| 176 | positive regulation of defense response to virus by host (GO:0002230) | 2.33692687 |
| 177 | amyloid precursor protein catabolic process (GO:0042987) | 2.32485885 |
| 178 | homocysteine metabolic process (GO:0050667) | 2.32242019 |
| 179 | protein-lipid complex remodeling (GO:0034368) | 2.32164956 |
| 180 | macromolecular complex remodeling (GO:0034367) | 2.32164956 |
| 181 | plasma lipoprotein particle remodeling (GO:0034369) | 2.32164956 |
| 182 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.31258297 |
| 183 | coenzyme catabolic process (GO:0009109) | 2.29693461 |
| 184 | cofactor catabolic process (GO:0051187) | 2.29131013 |
| 185 | serine family amino acid catabolic process (GO:0009071) | 2.28523991 |
| 186 | bile acid and bile salt transport (GO:0015721) | 2.27646774 |
| 187 | reverse cholesterol transport (GO:0043691) | 2.26998379 |
| 188 | granulocyte activation (GO:0036230) | 2.26884158 |
| 189 | triglyceride homeostasis (GO:0070328) | 2.26331482 |
| 190 | acylglycerol homeostasis (GO:0055090) | 2.26331482 |
| 191 | glyoxylate metabolic process (GO:0046487) | 2.25992167 |
| 192 | mannosylation (GO:0097502) | 2.25911324 |
| 193 | centriole replication (GO:0007099) | 2.25652945 |
| 194 | response to hyperoxia (GO:0055093) | 2.25570603 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.86332432 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.38988286 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.82703609 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.51648332 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.27265369 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.27232015 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.90558967 |
| 8 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.89116045 |
| 9 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.84974049 |
| 10 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.82816546 |
| 11 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.81244528 |
| 12 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.76895618 |
| 13 | MYB_26560356_Chip-Seq_TH2_Human | 2.74721098 |
| 14 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.74108258 |
| 15 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.73463918 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.67399689 |
| 17 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.67388316 |
| 18 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.65611575 |
| 19 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.62777929 |
| 20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.52606092 |
| 21 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 2.37187883 |
| 22 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 2.33129068 |
| 23 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.30156142 |
| 24 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.20640935 |
| 25 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.19731909 |
| 26 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.19248357 |
| 27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.18599797 |
| 28 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.18527309 |
| 29 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.16850624 |
| 30 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.11778483 |
| 31 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.11070944 |
| 32 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.10270365 |
| 33 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.08556219 |
| 34 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 2.07950628 |
| 35 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.07784013 |
| 36 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.06139304 |
| 37 | MYB_26560356_Chip-Seq_TH1_Human | 2.06021374 |
| 38 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.05977985 |
| 39 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.02859674 |
| 40 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.02256722 |
| 41 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 2.01642267 |
| 42 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.97740139 |
| 43 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.95670036 |
| 44 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.87472885 |
| 45 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.81427814 |
| 46 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.81138881 |
| 47 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.80991560 |
| 48 | GATA1_22025678_ChIP-Seq_K562_Human | 1.80547794 |
| 49 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.79740201 |
| 50 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.79434012 |
| 51 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.79357960 |
| 52 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.76895453 |
| 53 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.75500199 |
| 54 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.75176943 |
| 55 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.74571510 |
| 56 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.74078975 |
| 57 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.74009563 |
| 58 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.73385598 |
| 59 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.71004352 |
| 60 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.70205735 |
| 61 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.68429851 |
| 62 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.65784971 |
| 63 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.65696554 |
| 64 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.64971551 |
| 65 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.64189685 |
| 66 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.61998153 |
| 67 | GATA3_26560356_Chip-Seq_TH2_Human | 1.61125584 |
| 68 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60518361 |
| 69 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.58877010 |
| 70 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.58575416 |
| 71 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.58310244 |
| 72 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.55205782 |
| 73 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.54682877 |
| 74 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.54532728 |
| 75 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.53715312 |
| 76 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.52828208 |
| 77 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.52544251 |
| 78 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.51989834 |
| 79 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.51442226 |
| 80 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.50920991 |
| 81 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.48436199 |
| 82 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.48190504 |
| 83 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.46020075 |
| 84 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.44989167 |
| 85 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.44335651 |
| 86 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43947436 |
| 87 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.42654331 |
| 88 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.41532270 |
| 89 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.41408850 |
| 90 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.40421950 |
| 91 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.40272384 |
| 92 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.39651409 |
| 93 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.39007689 |
| 94 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.38009080 |
| 95 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.36968744 |
| 96 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.34032160 |
| 97 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.33154918 |
| 98 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.32305937 |
| 99 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.29772686 |
| 100 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28676128 |
| 101 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.27378281 |
| 102 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.27063591 |
| 103 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.26472898 |
| 104 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.25006899 |
| 105 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.23837084 |
| 106 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23440832 |
| 107 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.22121816 |
| 108 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.20747958 |
| 109 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.20401040 |
| 110 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.20113699 |
| 111 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.18878863 |
| 112 | MAF_26560356_Chip-Seq_TH1_Human | 1.18715654 |
| 113 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18454541 |
| 114 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.17549810 |
| 115 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.12988628 |
| 116 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.12766430 |
| 117 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.10754783 |
| 118 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.10337821 |
| 119 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10309410 |
| 120 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.10142463 |
| 121 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.10125509 |
| 122 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.09701145 |
| 123 | MYC_22102868_ChIP-Seq_BL_Human | 1.08736145 |
| 124 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07999474 |
| 125 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.07645235 |
| 126 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07112120 |
| 127 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.06346706 |
| 128 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05187636 |
| 129 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.04856652 |
| 130 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.04336645 |
| 131 | P300_19829295_ChIP-Seq_ESCs_Human | 1.02535498 |
| 132 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.02480821 |
| 133 | UTX_26944678_Chip-Seq_JUKART_Human | 1.02060474 |
| 134 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.00527093 |
| 135 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.00052095 |
| 136 | MAF_26560356_Chip-Seq_TH2_Human | 0.99794209 |
| 137 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.98539727 |
| 138 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.98361707 |
| 139 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.98186244 |
| 140 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.98007858 |
| 141 | VDR_22108803_ChIP-Seq_LS180_Human | 0.96079139 |
| 142 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94915234 |
| 143 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.94508784 |
| 144 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.92895801 |
| 145 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.92292929 |
| 146 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.92052108 |
| 147 | KDM2B_26808549_Chip-Seq_REH_Human | 0.91958230 |
| 148 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.91094808 |
| 149 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.90783528 |
| 150 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.89224607 |
| 151 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.88923960 |
| 152 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.88821722 |
| 153 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88580322 |
| 154 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.88177259 |
| 155 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.86512750 |
| 156 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.86444259 |
| 157 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.86294569 |
| 158 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.85903384 |
| 159 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.85222882 |
| 160 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.85002349 |
| 161 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.84548920 |
| 162 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.83586159 |
| 163 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.83281373 |
| 164 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.82031162 |
| 165 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.81447931 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.33418233 |
| 2 | MP0005360_urolithiasis | 3.18508748 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 3.15089440 |
| 4 | MP0009333_abnormal_splenocyte_physiolog | 3.11217315 |
| 5 | MP0005365_abnormal_bile_salt | 2.88428249 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.79472078 |
| 7 | MP0004381_abnormal_hair_follicle | 2.74975789 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 2.73397312 |
| 9 | MP0003724_increased_susceptibility_to | 2.59803188 |
| 10 | MP0004782_abnormal_surfactant_physiolog | 2.59121621 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 2.48400961 |
| 12 | MP0009785_altered_susceptibility_to | 2.32986393 |
| 13 | MP0002166_altered_tumor_susceptibility | 2.24520624 |
| 14 | MP0001873_stomach_inflammation | 2.22442995 |
| 15 | MP0005671_abnormal_response_to | 2.17020938 |
| 16 | MP0006292_abnormal_olfactory_placode | 2.14842819 |
| 17 | MP0001790_abnormal_immune_system | 2.09497269 |
| 18 | MP0005387_immune_system_phenotype | 2.09497269 |
| 19 | MP0003136_yellow_coat_color | 2.08042945 |
| 20 | MP0003436_decreased_susceptibility_to | 2.03922294 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 1.99501234 |
| 22 | MP0001800_abnormal_humoral_immune | 1.92258941 |
| 23 | MP0003806_abnormal_nucleotide_metabolis | 1.92161087 |
| 24 | MP0002876_abnormal_thyroid_physiology | 1.85712076 |
| 25 | MP0005000_abnormal_immune_tolerance | 1.85373208 |
| 26 | MP0000566_synostosis | 1.84609184 |
| 27 | MP0002277_abnormal_respiratory_mucosa | 1.84045612 |
| 28 | MP0005025_abnormal_response_to | 1.82851693 |
| 29 | MP0003252_abnormal_bile_duct | 1.81602112 |
| 30 | MP0009764_decreased_sensitivity_to | 1.80676800 |
| 31 | MP0002132_abnormal_respiratory_system | 1.79786942 |
| 32 | MP0000685_abnormal_immune_system | 1.77066074 |
| 33 | MP0000516_abnormal_urinary_system | 1.76898954 |
| 34 | MP0005367_renal/urinary_system_phenotyp | 1.76898954 |
| 35 | MP0005075_abnormal_melanosome_morpholog | 1.76019189 |
| 36 | MP0010307_abnormal_tumor_latency | 1.69790821 |
| 37 | MP0002419_abnormal_innate_immunity | 1.69493530 |
| 38 | MP0000703_abnormal_thymus_morphology | 1.68501293 |
| 39 | MP0009379_abnormal_foot_pigmentation | 1.68107340 |
| 40 | MP0002723_abnormal_immune_serum | 1.67846854 |
| 41 | MP0008995_early_reproductive_senescence | 1.64659928 |
| 42 | MP0002452_abnormal_antigen_presenting | 1.63821351 |
| 43 | MP0003011_delayed_dark_adaptation | 1.63699042 |
| 44 | MP0010094_abnormal_chromosome_stability | 1.54604299 |
| 45 | MP0005310_abnormal_salivary_gland | 1.53941437 |
| 46 | MP0005409_darkened_coat_color | 1.50864310 |
| 47 | MP0001188_hyperpigmentation | 1.49639423 |
| 48 | MP0003195_calcinosis | 1.49616703 |
| 49 | MP0003693_abnormal_embryo_hatching | 1.49102617 |
| 50 | MP0003868_abnormal_feces_composition | 1.46791778 |
| 51 | MP0003718_maternal_effect | 1.44064210 |
| 52 | MP0001764_abnormal_homeostasis | 1.43223274 |
| 53 | MP0009697_abnormal_copulation | 1.41917482 |
| 54 | MP0000465_gastrointestinal_hemorrhage | 1.41301049 |
| 55 | MP0002420_abnormal_adaptive_immunity | 1.39524661 |
| 56 | MP0001819_abnormal_immune_cell | 1.39319781 |
| 57 | MP0000015_abnormal_ear_pigmentation | 1.37489659 |
| 58 | MP0008260_abnormal_autophagy | 1.35713923 |
| 59 | MP0003300_gastrointestinal_ulcer | 1.35378866 |
| 60 | MP0002163_abnormal_gland_morphology | 1.33916946 |
| 61 | MP0005332_abnormal_amino_acid | 1.33843611 |
| 62 | MP0005408_hypopigmentation | 1.33552494 |
| 63 | MP0008469_abnormal_protein_level | 1.32261865 |
| 64 | MP0004019_abnormal_vitamin_homeostasis | 1.31803932 |
| 65 | MP0001853_heart_inflammation | 1.30961326 |
| 66 | MP0003763_abnormal_thymus_physiology | 1.28732326 |
| 67 | MP0005174_abnormal_tail_pigmentation | 1.27315829 |
| 68 | MP0002019_abnormal_tumor_incidence | 1.26120091 |
| 69 | MP0010329_abnormal_lipoprotein_level | 1.25628450 |
| 70 | MP0003191_abnormal_cellular_cholesterol | 1.22158836 |
| 71 | MP0000858_altered_metastatic_potential | 1.21042197 |
| 72 | MP0003866_abnormal_defecation | 1.19754086 |
| 73 | MP0005451_abnormal_body_composition | 1.19425842 |
| 74 | MP0001986_abnormal_taste_sensitivity | 1.16512803 |
| 75 | MP0006082_CNS_inflammation | 1.16295523 |
| 76 | MP0001845_abnormal_inflammatory_respons | 1.15169973 |
| 77 | MP0003186_abnormal_redox_activity | 1.13931587 |
| 78 | MP0005647_abnormal_sex_gland | 1.11016656 |
| 79 | MP0008058_abnormal_DNA_repair | 1.10526360 |
| 80 | MP0000716_abnormal_immune_system | 1.07810394 |
| 81 | MP0001666_abnormal_nutrient_absorption | 1.06099770 |
| 82 | MP0002009_preneoplasia | 1.05592470 |
| 83 | MP0005464_abnormal_platelet_physiology | 1.03827026 |
| 84 | MP0000490_abnormal_crypts_of | 1.03363484 |
| 85 | MP0009765_abnormal_xenobiotic_induced | 1.01825244 |
| 86 | MP0009840_abnormal_foam_cell | 1.01792634 |
| 87 | MP0009763_increased_sensitivity_to | 1.00575452 |
| 88 | MP0002095_abnormal_skin_pigmentation | 1.00525788 |
| 89 | MP0003077_abnormal_cell_cycle | 0.98258184 |
| 90 | MP0002405_respiratory_system_inflammati | 0.98052870 |
| 91 | MP0000609_abnormal_liver_physiology | 0.97882671 |
| 92 | MP0000689_abnormal_spleen_morphology | 0.97184332 |
| 93 | MP0005389_reproductive_system_phenotype | 0.97135030 |
| 94 | MP0005083_abnormal_biliary_tract | 0.96312280 |
| 95 | MP0001348_abnormal_lacrimal_gland | 0.95679320 |
| 96 | MP0002118_abnormal_lipid_homeostasis | 0.91508534 |
| 97 | MP0000681_abnormal_thyroid_gland | 0.90503047 |
| 98 | MP0008057_abnormal_DNA_replication | 0.89132724 |
| 99 | MP0003303_peritoneal_inflammation | 0.86895307 |
| 100 | MP0002398_abnormal_bone_marrow | 0.86437848 |
| 101 | MP0010155_abnormal_intestine_physiology | 0.86321655 |
| 102 | MP0004947_skin_inflammation | 0.83936650 |
| 103 | MP0003448_altered_tumor_morphology | 0.83042812 |
| 104 | MP0001533_abnormal_skeleton_physiology | 0.81441491 |
| 105 | MP0002160_abnormal_reproductive_system | 0.80543166 |
| 106 | MP0005084_abnormal_gallbladder_morpholo | 0.80494078 |
| 107 | MP0006072_abnormal_retinal_apoptosis | 0.78268708 |
| 108 | MP0005379_endocrine/exocrine_gland_phen | 0.78063533 |
| 109 | MP0003786_premature_aging | 0.77744890 |
| 110 | MP0002429_abnormal_blood_cell | 0.76987541 |
| 111 | MP0001727_abnormal_embryo_implantation | 0.76094115 |
| 112 | MP0002722_abnormal_immune_system | 0.74930591 |
| 113 | MP0000372_irregular_coat_pigmentation | 0.73543192 |
| 114 | MP0005319_abnormal_enzyme/_coenzyme | 0.72053280 |
| 115 | MP0005171_absent_coat_pigmentation | 0.72011680 |
| 116 | MP0003567_abnormal_fetal_cardiomyocyte | 0.71146036 |
| 117 | MP0005395_other_phenotype | 0.70806947 |
| 118 | MP0008873_increased_physiological_sensi | 0.70375417 |
| 119 | MP0005551_abnormal_eye_electrophysiolog | 0.70366270 |
| 120 | MP0000613_abnormal_salivary_gland | 0.70144287 |
| 121 | MP0008872_abnormal_physiological_respon | 0.69556358 |
| 122 | MP0000538_abnormal_urinary_bladder | 0.69492970 |
| 123 | MP0002136_abnormal_kidney_physiology | 0.68028520 |
| 124 | MP0002254_reproductive_system_inflammat | 0.67319382 |
| 125 | MP0002098_abnormal_vibrissa_morphology | 0.66919934 |
| 126 | MP0005670_abnormal_white_adipose | 0.66735279 |
| 127 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.65840928 |
| 128 | MP0009643_abnormal_urine_homeostasis | 0.65640381 |
| 129 | MP0001919_abnormal_reproductive_system | 0.64814206 |
| 130 | MP0000371_diluted_coat_color | 0.64067199 |
| 131 | MP0005164_abnormal_response_to | 0.62363768 |
| 132 | MP0002006_tumorigenesis | 0.61339111 |
| 133 | MP0002933_joint_inflammation | 0.60350699 |
| 134 | MP0000604_amyloidosis | 0.58729441 |
| 135 | MP0001119_abnormal_female_reproductive | 0.58344417 |
| 136 | MP0000343_altered_response_to | 0.57991475 |
| 137 | MP0000569_abnormal_digit_pigmentation | 0.57925290 |
| 138 | MP0006054_spinal_hemorrhage | 0.57612465 |
| 139 | MP0003111_abnormal_nucleus_morphology | 0.57512683 |
| 140 | MP0002693_abnormal_pancreas_physiology | 0.57421767 |
| 141 | MP0000313_abnormal_cell_death | 0.57110167 |
| 142 | MP0001663_abnormal_digestive_system | 0.56131129 |
| 143 | MP0004957_abnormal_blastocyst_morpholog | 0.55742701 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Inflammation of the large intestine (HP:0002037) | 4.47984407 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 4.27205268 |
| 3 | Panhypogammaglobulinemia (HP:0003139) | 4.15649397 |
| 4 | Gastrointestinal inflammation (HP:0004386) | 4.12872140 |
| 5 | IgG deficiency (HP:0004315) | 4.12024565 |
| 6 | Joint hemorrhage (HP:0005261) | 4.02909596 |
| 7 | B lymphocytopenia (HP:0010976) | 3.91536160 |
| 8 | Recurrent bronchitis (HP:0002837) | 3.79264038 |
| 9 | Abnormality of B cell number (HP:0010975) | 3.77921312 |
| 10 | T lymphocytopenia (HP:0005403) | 3.63613853 |
| 11 | Abnormality of T cell number (HP:0011839) | 3.58166017 |
| 12 | Intrahepatic cholestasis (HP:0001406) | 3.56205612 |
| 13 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.51059034 |
| 14 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.46657326 |
| 15 | Recurrent viral infections (HP:0004429) | 3.46634450 |
| 16 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.37315256 |
| 17 | Abnormality of T cells (HP:0002843) | 3.35570865 |
| 18 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.29507192 |
| 19 | Combined immunodeficiency (HP:0005387) | 3.15036893 |
| 20 | Reduced antithrombin III activity (HP:0001976) | 3.10934196 |
| 21 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.10529800 |
| 22 | Pulmonary infiltrates (HP:0002113) | 2.99326321 |
| 23 | Abnormality of T cell physiology (HP:0011840) | 2.97272450 |
| 24 | Thyroid-stimulating hormone excess (HP:0002925) | 2.94135117 |
| 25 | Thyroiditis (HP:0100646) | 2.89209588 |
| 26 | Lymphoma (HP:0002665) | 2.84687868 |
| 27 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.83880446 |
| 28 | Abnormality of methionine metabolism (HP:0010901) | 2.83679066 |
| 29 | Recurrent bacterial skin infections (HP:0005406) | 2.78513073 |
| 30 | Epidermoid cyst (HP:0200040) | 2.74277728 |
| 31 | Recurrent abscess formation (HP:0002722) | 2.72960355 |
| 32 | Chronic otitis media (HP:0000389) | 2.72096479 |
| 33 | Renal cortical cysts (HP:0000803) | 2.71344451 |
| 34 | Autoimmune hemolytic anemia (HP:0001890) | 2.70337553 |
| 35 | Chronic sinusitis (HP:0011109) | 2.68413595 |
| 36 | IgA deficiency (HP:0002720) | 2.66440125 |
| 37 | Recurrent sinusitis (HP:0011108) | 2.61768910 |
| 38 | Type I transferrin isoform profile (HP:0003642) | 2.56001504 |
| 39 | Hypoproteinemia (HP:0003075) | 2.51412767 |
| 40 | Hyperlipoproteinemia (HP:0010980) | 2.48945733 |
| 41 | Eczematoid dermatitis (HP:0000976) | 2.47627141 |
| 42 | Aplastic anemia (HP:0001915) | 2.46960990 |
| 43 | Bronchitis (HP:0012387) | 2.44769081 |
| 44 | Parakeratosis (HP:0001036) | 2.43282488 |
| 45 | Abnormality of eosinophils (HP:0001879) | 2.42862921 |
| 46 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.42654555 |
| 47 | Colon cancer (HP:0003003) | 2.42078929 |
| 48 | Complement deficiency (HP:0004431) | 2.41432626 |
| 49 | Prostate neoplasm (HP:0100787) | 2.39610882 |
| 50 | Eosinophilia (HP:0001880) | 2.38956223 |
| 51 | Papilloma (HP:0012740) | 2.38795217 |
| 52 | Verrucae (HP:0200043) | 2.38795217 |
| 53 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.38405770 |
| 54 | Stomatitis (HP:0010280) | 2.38196391 |
| 55 | Retrobulbar optic neuritis (HP:0100654) | 2.38163596 |
| 56 | Optic neuritis (HP:0100653) | 2.38163596 |
| 57 | Meningitis (HP:0001287) | 2.34419843 |
| 58 | Vasculitis (HP:0002633) | 2.33742002 |
| 59 | Tubulointerstitial nephritis (HP:0001970) | 2.30568659 |
| 60 | Abnormality of macrophages (HP:0004311) | 2.30229589 |
| 61 | Hypoplasia of the thymus (HP:0000778) | 2.30153992 |
| 62 | Recurrent pneumonia (HP:0006532) | 2.29386759 |
| 63 | Abnormality of the common coagulation pathway (HP:0010990) | 2.29218752 |
| 64 | Interstitial pulmonary disease (HP:0006530) | 2.28789722 |
| 65 | Conjugated hyperbilirubinemia (HP:0002908) | 2.27236285 |
| 66 | Acute necrotizing encephalopathy (HP:0006965) | 2.26381935 |
| 67 | Mediastinal lymphadenopathy (HP:0100721) | 2.25994268 |
| 68 | Hypobetalipoproteinemia (HP:0003563) | 2.24248376 |
| 69 | Emphysema (HP:0002097) | 2.23242718 |
| 70 | Fat malabsorption (HP:0002630) | 2.22065749 |
| 71 | Agammaglobulinemia (HP:0004432) | 2.21314067 |
| 72 | Mitochondrial inheritance (HP:0001427) | 2.18567951 |
| 73 | Neutropenia (HP:0001875) | 2.18476017 |
| 74 | Recurrent skin infections (HP:0001581) | 2.18211150 |
| 75 | Restrictive lung disease (HP:0002091) | 2.15466988 |
| 76 | Stomach cancer (HP:0012126) | 2.14703526 |
| 77 | Leukocytosis (HP:0001974) | 2.13250999 |
| 78 | Gingival bleeding (HP:0000225) | 2.12521852 |
| 79 | Chromsome breakage (HP:0040012) | 2.11984994 |
| 80 | Xanthomatosis (HP:0000991) | 2.11892985 |
| 81 | Leukopenia (HP:0001882) | 2.11033053 |
| 82 | Exertional dyspnea (HP:0002875) | 2.09799553 |
| 83 | Glomerulonephritis (HP:0000099) | 2.07792311 |
| 84 | Microcytic anemia (HP:0001935) | 2.06587197 |
| 85 | Orchitis (HP:0100796) | 2.06200999 |
| 86 | Prolonged neonatal jaundice (HP:0006579) | 2.06137625 |
| 87 | Alveolar cell carcinoma (HP:0006519) | 2.05716163 |
| 88 | Abnormality of the axillary hair (HP:0100134) | 2.05620128 |
| 89 | Abnormality of secondary sexual hair (HP:0009888) | 2.05620128 |
| 90 | Deep venous thrombosis (HP:0002625) | 2.04834039 |
| 91 | Congenital, generalized hypertrichosis (HP:0004540) | 2.04675157 |
| 92 | Increased CSF lactate (HP:0002490) | 2.04456139 |
| 93 | Encephalitis (HP:0002383) | 2.04230340 |
| 94 | Hepatocellular necrosis (HP:0001404) | 2.03420054 |
| 95 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.01807692 |
| 96 | Azoospermia (HP:0000027) | 2.01170505 |
| 97 | Steatorrhea (HP:0002570) | 2.00876277 |
| 98 | Pulmonary fibrosis (HP:0002206) | 1.99457257 |
| 99 | Decreased central vision (HP:0007663) | 1.99412404 |
| 100 | Progressive macrocephaly (HP:0004481) | 1.98780247 |
| 101 | Hemoptysis (HP:0002105) | 1.97268944 |
| 102 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.97243584 |
| 103 | Myositis (HP:0100614) | 1.95892414 |
| 104 | Abnormality of the pleura (HP:0002103) | 1.95820887 |
| 105 | Chest pain (HP:0100749) | 1.95540124 |
| 106 | Methylmalonic aciduria (HP:0012120) | 1.95483114 |
| 107 | IgM deficiency (HP:0002850) | 1.94951364 |
| 108 | Pancreatic cysts (HP:0001737) | 1.93217773 |
| 109 | Colitis (HP:0002583) | 1.93133512 |
| 110 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.92959058 |
| 111 | Obstructive lung disease (HP:0006536) | 1.92631694 |
| 112 | Chronic obstructive pulmonary disease (HP:0006510) | 1.92631694 |
| 113 | Abnormal glycosylation (HP:0012345) | 1.92535878 |
| 114 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.92535878 |
| 115 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.92535878 |
| 116 | Abnormal protein glycosylation (HP:0012346) | 1.92535878 |
| 117 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.91528436 |
| 118 | Systemic lupus erythematosus (HP:0002725) | 1.90502214 |
| 119 | Vascular calcification (HP:0004934) | 1.90448709 |
| 120 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.90252949 |
| 121 | Granulocytopenia (HP:0001913) | 1.88726630 |
| 122 | Dry hair (HP:0011359) | 1.88567775 |
| 123 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.88029054 |
| 124 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.87751024 |
| 125 | Hypoalbuminemia (HP:0003073) | 1.87575810 |
| 126 | Abnormal albumin level (HP:0012116) | 1.87575810 |
| 127 | Methylmalonic acidemia (HP:0002912) | 1.87050407 |
| 128 | Cleft eyelid (HP:0000625) | 1.86104453 |
| 129 | Abnormality of complement system (HP:0005339) | 1.86001930 |
| 130 | Increased IgM level (HP:0003496) | 1.85145076 |
| 131 | Renal Fanconi syndrome (HP:0001994) | 1.84857657 |
| 132 | Abnormality of the prostate (HP:0008775) | 1.83995753 |
| 133 | Recurrent cutaneous fungal infections (HP:0011370) | 1.83961107 |
| 134 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.83961107 |
| 135 | Global brain atrophy (HP:0002283) | 1.82482899 |
| 136 | Gastrointestinal stroma tumor (HP:0100723) | 1.81725324 |
| 137 | 3-Methylglutaconic aciduria (HP:0003535) | 1.80794168 |
| 138 | Abnormality of male internal genitalia (HP:0000022) | 1.80776309 |
| 139 | Fair hair (HP:0002286) | 1.79614599 |
| 140 | Absent/shortened dynein arms (HP:0200106) | 1.79331616 |
| 141 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.79331616 |
| 142 | Chronic diarrhea (HP:0002028) | 1.79216890 |
| 143 | Hypochromic anemia (HP:0001931) | 1.78451161 |
| 144 | Thrombocytosis (HP:0001894) | 1.77593279 |
| 145 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.77474623 |
| 146 | Pancytopenia (HP:0001876) | 1.76631886 |
| 147 | Type 2 muscle fiber atrophy (HP:0003554) | 1.76621274 |
| 148 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.75798368 |
| 149 | Recurrent lower respiratory tract infections (HP:0002783) | 1.74914115 |
| 150 | Abnormality of the renal cortex (HP:0011035) | 1.73764323 |
| 151 | Osteomalacia (HP:0002749) | 1.72137035 |
| 152 | Recurrent fungal infections (HP:0002841) | 1.72016527 |
| 153 | Clubbing of toes (HP:0100760) | 1.72001479 |
| 154 | Menorrhagia (HP:0000132) | 1.71331598 |
| 155 | Epistaxis (HP:0000421) | 1.70904251 |
| 156 | Respiratory distress (HP:0002098) | 1.69838566 |
| 157 | Lymphopenia (HP:0001888) | 1.69733550 |
| 158 | Abnormality of nucleobase metabolism (HP:0010932) | 1.69628187 |
| 159 | Severe combined immunodeficiency (HP:0004430) | 1.68760194 |
| 160 | Cheilitis (HP:0100825) | 1.67928172 |
| 161 | Abnormal spermatogenesis (HP:0008669) | 1.66783501 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 4.53547971 |
| 2 | IRAK4 | 3.42831008 |
| 3 | VRK2 | 3.30631894 |
| 4 | CASK | 3.05079648 |
| 5 | STK16 | 2.83929773 |
| 6 | MAP3K14 | 2.59822766 |
| 7 | IRAK1 | 2.57601569 |
| 8 | IRAK2 | 2.37835312 |
| 9 | TXK | 2.19018068 |
| 10 | NLK | 2.01263479 |
| 11 | MUSK | 1.96801126 |
| 12 | TNIK | 1.94056371 |
| 13 | MAP4K2 | 1.90424346 |
| 14 | MAP4K1 | 1.78506359 |
| 15 | PLK4 | 1.76515382 |
| 16 | ZAK | 1.67820767 |
| 17 | BMPR1B | 1.63609144 |
| 18 | IKBKE | 1.63080154 |
| 19 | TEC | 1.55233691 |
| 20 | IKBKB | 1.53006239 |
| 21 | MST4 | 1.52776440 |
| 22 | PBK | 1.51331706 |
| 23 | CLK1 | 1.49825037 |
| 24 | BLK | 1.49362697 |
| 25 | PASK | 1.49010917 |
| 26 | MKNK2 | 1.48292169 |
| 27 | EIF2AK3 | 1.46221334 |
| 28 | ERN1 | 1.41029511 |
| 29 | INSRR | 1.40469601 |
| 30 | YES1 | 1.38806781 |
| 31 | EIF2AK2 | 1.36705032 |
| 32 | SRPK1 | 1.27262729 |
| 33 | GRK1 | 1.24469535 |
| 34 | TAOK3 | 1.23028357 |
| 35 | TLK1 | 1.19971175 |
| 36 | TESK2 | 1.15776714 |
| 37 | CDC7 | 1.15384439 |
| 38 | TBK1 | 1.15371792 |
| 39 | CDK3 | 1.13332800 |
| 40 | BMPR2 | 1.12599731 |
| 41 | BCKDK | 1.10609494 |
| 42 | TYK2 | 1.10604114 |
| 43 | BTK | 1.09470585 |
| 44 | NUAK1 | 1.07663185 |
| 45 | GRK7 | 1.05972426 |
| 46 | CSF1R | 1.04668432 |
| 47 | VRK1 | 1.04547856 |
| 48 | MAP3K12 | 1.03508257 |
| 49 | STK24 | 1.00312673 |
| 50 | AKT3 | 0.97164260 |
| 51 | SIK3 | 0.96654356 |
| 52 | EIF2AK1 | 0.96433977 |
| 53 | NEK6 | 0.94561285 |
| 54 | KIT | 0.94423554 |
| 55 | FES | 0.93412808 |
| 56 | LYN | 0.92508178 |
| 57 | CAMKK2 | 0.91546659 |
| 58 | PRPF4B | 0.91349920 |
| 59 | GRK6 | 0.91082183 |
| 60 | EPHA3 | 0.90397462 |
| 61 | BRAF | 0.87941436 |
| 62 | ZAP70 | 0.87845772 |
| 63 | FGFR4 | 0.87542084 |
| 64 | TRIM28 | 0.86600865 |
| 65 | MKNK1 | 0.86331105 |
| 66 | FRK | 0.85067184 |
| 67 | MAPK15 | 0.84686031 |
| 68 | BRSK2 | 0.83504015 |
| 69 | PKN1 | 0.83150134 |
| 70 | TGFBR2 | 0.82274628 |
| 71 | JAK3 | 0.82222075 |
| 72 | ERBB4 | 0.81190117 |
| 73 | ADRBK2 | 0.80442735 |
| 74 | SYK | 0.79606285 |
| 75 | MAP2K7 | 0.77924847 |
| 76 | TAF1 | 0.74070239 |
| 77 | ATR | 0.73982079 |
| 78 | MARK3 | 0.73912298 |
| 79 | JAK1 | 0.70426236 |
| 80 | WEE1 | 0.68919740 |
| 81 | PRKCH | 0.68824769 |
| 82 | PIM1 | 0.68324672 |
| 83 | ACVR1B | 0.67568947 |
| 84 | CHUK | 0.65644412 |
| 85 | BUB1 | 0.65237546 |
| 86 | PRKCQ | 0.65101615 |
| 87 | CDK19 | 0.64931574 |
| 88 | PIM2 | 0.64656790 |
| 89 | CSK | 0.64429339 |
| 90 | TNK2 | 0.61303292 |
| 91 | LCK | 0.60978481 |
| 92 | CDK8 | 0.59210324 |
| 93 | BRD4 | 0.59082494 |
| 94 | PRKD2 | 0.58204320 |
| 95 | STK4 | 0.57510566 |
| 96 | RIPK4 | 0.56188182 |
| 97 | ITK | 0.55731288 |
| 98 | MAP3K13 | 0.55360555 |
| 99 | STK38L | 0.54578334 |
| 100 | KDR | 0.54515438 |
| 101 | TTK | 0.54350492 |
| 102 | PIK3CG | 0.53542089 |
| 103 | CSNK1G1 | 0.53232557 |
| 104 | PIK3CA | 0.52365746 |
| 105 | PRKCI | 0.52015760 |
| 106 | PINK1 | 0.50633688 |
| 107 | AURKB | 0.50108603 |
| 108 | MAPK7 | 0.50078846 |
| 109 | SGK2 | 0.50027043 |
| 110 | CAMK2G | 0.49472940 |
| 111 | NEK9 | 0.49343714 |
| 112 | ABL1 | 0.48971753 |
| 113 | RPS6KA5 | 0.48777386 |
| 114 | TIE1 | 0.48227031 |
| 115 | MAP2K2 | 0.47841547 |
| 116 | HCK | 0.47377796 |
| 117 | NME2 | 0.46625763 |
| 118 | CDK9 | 0.46340042 |
| 119 | ABL2 | 0.46202064 |
| 120 | CSNK1A1L | 0.45650664 |
| 121 | TGFBR1 | 0.44983549 |
| 122 | RPS6KA4 | 0.44865404 |
| 123 | STK10 | 0.43919200 |
| 124 | MST1R | 0.43337725 |
| 125 | MAPK4 | 0.42561321 |
| 126 | OXSR1 | 0.42422989 |
| 127 | CHEK1 | 0.39242193 |
| 128 | PDK2 | 0.38637517 |
| 129 | NEK1 | 0.37804617 |
| 130 | PRKCD | 0.36573851 |
| 131 | CSNK1G3 | 0.35822760 |
| 132 | MAPK11 | 0.35751417 |
| 133 | GRK5 | 0.35251676 |
| 134 | FGR | 0.34891659 |
| 135 | PLK1 | 0.32415965 |
| 136 | CCNB1 | 0.32297784 |
| 137 | CDK4 | 0.32291578 |
| 138 | CSNK2A2 | 0.32208518 |
| 139 | MELK | 0.31077114 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.19859001 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.00502797 |
| 3 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.94693297 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 2.47715412 |
| 5 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.31632422 |
| 6 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.26813250 |
| 7 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.23743486 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.18710221 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.18682133 |
| 10 | Histidine metabolism_Homo sapiens_hsa00340 | 2.16162853 |
| 11 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.11502726 |
| 12 | Retinol metabolism_Homo sapiens_hsa00830 | 2.11110737 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.10206344 |
| 14 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.09714135 |
| 15 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.07124645 |
| 16 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.03283071 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 1.93315942 |
| 18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.92570631 |
| 19 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.84390960 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.83928167 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.82391024 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.72578850 |
| 23 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.72223569 |
| 24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.71290190 |
| 25 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.69687885 |
| 26 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.67871582 |
| 27 | Viral myocarditis_Homo sapiens_hsa05416 | 1.64868218 |
| 28 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.62445745 |
| 29 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.59977012 |
| 30 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.57571063 |
| 31 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.57390696 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.55288807 |
| 33 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.54551708 |
| 34 | RNA degradation_Homo sapiens_hsa03018 | 1.54303668 |
| 35 | Mismatch repair_Homo sapiens_hsa03430 | 1.54286233 |
| 36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.53057426 |
| 37 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.49701236 |
| 38 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.44308493 |
| 39 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.43949900 |
| 40 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.38984127 |
| 41 | Spliceosome_Homo sapiens_hsa03040 | 1.36529510 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 1.32725020 |
| 43 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.32617419 |
| 44 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.32497286 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.31638630 |
| 46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.31458293 |
| 47 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.26933793 |
| 48 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.25841266 |
| 49 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.24668946 |
| 50 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.23936982 |
| 51 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.22538807 |
| 52 | Homologous recombination_Homo sapiens_hsa03440 | 1.21018364 |
| 53 | Allograft rejection_Homo sapiens_hsa05330 | 1.19552130 |
| 54 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.14850393 |
| 55 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.14301765 |
| 56 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.13257155 |
| 57 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.11246983 |
| 58 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.10320705 |
| 59 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.09244208 |
| 60 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.08760983 |
| 61 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.06677011 |
| 62 | Parkinsons disease_Homo sapiens_hsa05012 | 1.03403142 |
| 63 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.00198155 |
| 64 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.99830828 |
| 65 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.99302567 |
| 66 | Protein export_Homo sapiens_hsa03060 | 0.99252847 |
| 67 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.97318024 |
| 68 | Measles_Homo sapiens_hsa05162 | 0.92909648 |
| 69 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.92189811 |
| 70 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.92051936 |
| 71 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.91751629 |
| 72 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.90275494 |
| 73 | Tuberculosis_Homo sapiens_hsa05152 | 0.89798974 |
| 74 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.87431348 |
| 75 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.84937940 |
| 76 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.84508048 |
| 77 | Other glycan degradation_Homo sapiens_hsa00511 | 0.83344011 |
| 78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.82233525 |
| 79 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.81312433 |
| 80 | Phototransduction_Homo sapiens_hsa04744 | 0.80349853 |
| 81 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.78692091 |
| 82 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.77273520 |
| 83 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.76252192 |
| 84 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.75402978 |
| 85 | Malaria_Homo sapiens_hsa05144 | 0.74887758 |
| 86 | HTLV-I infection_Homo sapiens_hsa05166 | 0.74800818 |
| 87 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.74755385 |
| 88 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.74689960 |
| 89 | Sulfur relay system_Homo sapiens_hsa04122 | 0.74469905 |
| 90 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.74383590 |
| 91 | Leishmaniasis_Homo sapiens_hsa05140 | 0.73802277 |
| 92 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.73195350 |
| 93 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.72759555 |
| 94 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.72719821 |
| 95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.72287689 |
| 96 | RNA transport_Homo sapiens_hsa03013 | 0.72052626 |
| 97 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.71630907 |
| 98 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.71034058 |
| 99 | Cell cycle_Homo sapiens_hsa04110 | 0.70034444 |
| 100 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.68705491 |
| 101 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.67652711 |
| 102 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.66885272 |
| 103 | Apoptosis_Homo sapiens_hsa04210 | 0.66824655 |
| 104 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.66634645 |
| 105 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.66625141 |
| 106 | Alcoholism_Homo sapiens_hsa05034 | 0.65876604 |
| 107 | Pertussis_Homo sapiens_hsa05133 | 0.65057511 |
| 108 | Asthma_Homo sapiens_hsa05310 | 0.64818246 |
| 109 | Metabolic pathways_Homo sapiens_hsa01100 | 0.64734367 |
| 110 | DNA replication_Homo sapiens_hsa03030 | 0.63767873 |
| 111 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.63405175 |
| 112 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62500621 |
| 113 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.62455050 |
| 114 | Huntingtons disease_Homo sapiens_hsa05016 | 0.60632696 |
| 115 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.60111848 |
| 116 | Base excision repair_Homo sapiens_hsa03410 | 0.59478668 |
| 117 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.58277536 |
| 118 | Basal transcription factors_Homo sapiens_hsa03022 | 0.58087304 |
| 119 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.55981059 |
| 120 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.55799796 |
| 121 | Legionellosis_Homo sapiens_hsa05134 | 0.54678841 |
| 122 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.53861695 |
| 123 | Shigellosis_Homo sapiens_hsa05131 | 0.50709932 |
| 124 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.48449269 |
| 125 | Purine metabolism_Homo sapiens_hsa00230 | 0.48073567 |
| 126 | Alzheimers disease_Homo sapiens_hsa05010 | 0.47785197 |
| 127 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.47704282 |
| 128 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.45998929 |
| 129 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.45872812 |
| 130 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45620773 |
| 131 | RNA polymerase_Homo sapiens_hsa03020 | 0.45270773 |
| 132 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.44347937 |
| 133 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.43631646 |
| 134 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.43302782 |
| 135 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.40431919 |
| 136 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.39925302 |
| 137 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.39895672 |
| 138 | Influenza A_Homo sapiens_hsa05164 | 0.37860771 |
| 139 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35625082 |
| 140 | Hepatitis B_Homo sapiens_hsa05161 | 0.31895677 |
| 141 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.25012011 |
| 142 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.22253751 |
| 143 | Hepatitis C_Homo sapiens_hsa05160 | 0.21291318 |
| 144 | Phagosome_Homo sapiens_hsa04145 | 0.16717271 |
| 145 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.16675167 |
| 146 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.16091173 |
| 147 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.15942527 |
| 148 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.13936576 |

